You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Moodys
Mallinckrodt
Medtronic
Express Scripts

Last Updated: February 19, 2020

DrugPatentWatch Database Preview

Trastuzumab; hyaluronidase-oysk - Biologic Drug Details


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Summary for trastuzumab; hyaluronidase-oysk
Recent Litigation for trastuzumab; hyaluronidase-oysk

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD.2019-07-12
Genentech, Inc. v. Pfizer Inc.2019-04-05
Genentech, Inc. v. Immunex Rhode Island Corp.2019-03-29

See all trastuzumab; hyaluronidase-oysk litigation

PTAB Litigation
PetitionerDate
GEMoaB Monoclonals GmbH2019-12-20
2018-01-08
2017-06-30

See all trastuzumab; hyaluronidase-oysk litigation

Patent Text Search: US Patents for trastuzumab; hyaluronidase-oysk

These patents were identified by searching patent claims

Supplementary Protection Certificates for trastuzumab; hyaluronidase-oysk

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
15/020 Ireland   Start Trial PRODUCT NAME: IBRUTINIB, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/14/945 20141021
1 50004-2013 Slovakia   Start Trial PRODUCT NAME: TRASTUZUMAB EMTANSIN; REGISTRATION NO/DATE: EU/1/13/885/001 - EU/1/13/885/002 20131119
2013028 Lithuania   Start Trial PRODUCT NAME: TRASTUZUMABUM EMTANSINUM; REGISTRATION NO/DATE: EU/1/13/885 20131115
2016000093 Germany   Start Trial PRODUCT NAME: LBRUTINIB ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/14/945 20160526
0822 Netherlands   Start Trial PRODUCT NAME: RITUXIMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/98/067/003 - UITVOERINGSBESLUIT C(2014)2048 20140326
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Merck
Moodys
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.